Need advice in managing cancer immunotherapy cardiotoxicity?

Request Assistance

FDA Public Workshop: Assessment of Cardiovascular Toxicities in Immuno-oncology Trials
Posted by Moslehi on January 22, 2018

On Friday, December 1, 2017, the U.S. Food & Drug Administration (FDA) announced a public workshop entitled, “Assessment of Cardiovascular Toxicities in Immuno-oncology Trials”. This workshop provided a forum for discussion of cardiovascular toxicities in immuno-oncology clinical trials. The workshop focused on the identification...

Read More
Manuscripts published in Circulation raise awareness for immune checkpoint inhibitor associated myocarditis
Posted by Moslehi on January 22, 2018

Two manuscripts published on November 21, 2017 of the journal Circulation bring additional awareness for the syndrome of immune checkpoint-inhibitor (ICI)-associated myocarditis. Thuny and colleagues (Hospital Nord, Marseille, France) present a case series of 30 patients with ICI-induced cardiotoxicity. Cardiotoxicity was diagnosed at a...

Read More
Cardio-Oncology highlighted at American Heart Association Annual Meeting 2017
Posted by Moslehi on January 22, 2018

There were several cardio-oncology sessions at the American Heart Association (AHA) annual meeting which occurred in November 2017 in Anaheim, California. A session called “The Emerging Science of Cardio-Oncology” focused on the rapidly evolving area of clinical practice in cancer patients with heart failure or acute coronary...

Read More
View All
connect with us

Great leadership by @Joseph_C_Wu organizing this @nih_nhlbi conference focused on physician-scientists & medical student research. Great speakers including Dr. Lefkowitz on the Yellow Berets! @StanfordCVI @josephahill AHA @HeartNews in good hands!

Only 4 weeks left until the first European Meeting decicated to #cardioimmunology. Updated program: with
18 invited speakers,
11 oral presentations selected from abstracts,
43 posters and >120 delegates at the meeting.

Metabolic cancer gene mutations & CV disease! UCSF #CardioOnc Conference w/ @drycm2d presenting a case of SDH mutant paraganglioma. @AnjaKarlstaedt serving as discussant! @baik_alan @AmirZMunir @LorenzLehmann @JayaMallidi @JuanQinMed @ShaoyiZhang88 @MandarArasMD @DrEimanJ

Mechanisms of Immuno-oncology Toxicity:
@DrRobinReschke, Javid Moslehi @CardioOncology, and Ryan J. Sullivan will address this topic in a plenary session at the AACR Special Conference on Tumor Immunology and Immunotherapy (Oct 21-24, Boston).